close
Prof. Serap Hastürk, M.D.

Prof. Serap Hastürk

Place and Date of Birth: Adana, 1956
Foreign Language: English
Field of Specialty: Pulmonologist and Tuberculosis Specialist 

Curriculum Vitae of Doctor

Education
  • 2002 Title of Professor, Pulmonology Department Çukurova University Adana
  • 1996 Title of Associate Professor, Pulmonology Department Çukurova University Adana
  • 1995 Residency, Oncology Institute Hacettepe University Medical Oncology Residency
  • 1990 Medical Residency Pulmonologist and Tuberculosis Specialist , Atatürk Pulmonology and Thoracic Surgery Center, Ankara
  • 1981 Bachelor’s degree, Ege University School of Medicine
 
Professional Experiences
  • 2020-... İstanbul Cerrahi Hospital Pulmonology, Professor
  • 2017-2013 Yedikule Pulmonology Hospital Istanbul, Lecturer
  • 2013-2010 Yedikule Pulmonology Hospital Istanbul, Medical Doctor
  • 2010-2002 Pulmonology Department Çukurova University Adana, Professor
  • 2002-1999 Pulmonology Department Çukurova University Adana, Associate Professor
  • 1999-1998 MD Anderson Kanser Merkezi, Houston ABD “Dept of Thoracic Head & Neck Medical Oncology” Research Assistant
  • 1995-1999 Pulmonology Department Çukurova University Adana,  Assist. Prof.
  • 1995-1994 Pulmonology Department Çukurova University Adana,  Lecturer
  • 1994-1990 Atatürk Pulmonology and Thoracic Surgery Center Ankara, Chief Resident , Attending Physician
  • 1990-1986 Atatürk Pulmonology and Thoracic Surgery Center Ankara, Resident
  • 1986-1984 PTT Evleri Health Clinic, Conscription, Adana, Medical Doctor
  • 1984-1982 Mardin Health Clinic No 1, Conscription, Adana, Medical Doctor
 
Fields of Experiences
  • Diagnosis, staging, treatment and palliation of lung and pleura cancers.
  • Diagnosis and treatment of pleural diseases
  • Diagnosis, treatment and management of Chronic Obstructive Pulmonary Disease (COPD)
  • Diagnosis, treatment and management of asthma (allergic- non allergic)
  • Diagnosis and treatment in lung infections
  • Diagnosis, treatments and prophylaxis of Pulmonary embolism
  • Diagnosis and Treatment of Interstitial Lung Diseases
  • Bronchoscopic interventions (diagnostic and therapeutic)
  • Pulmonary function tests
 
Courses and Certificates
  • - Interventional Bronchoscopy Course: Hospital Sainte Marguerite, Marseille, October 4-6, 2006.
  • Trainers Training Seminar: UZUN, Training, Management and Consulting Services. Çukurova University School of Medicine September 2-3, 2002
  • Trainers Training Seminar: DOOR Training International. Çukurova University School of Medicine March 11-13, 2003.
  • Educational Skills Development Course. Officers of IU İstanbul School of Medicine, Medical Science Application and Research Center. Çukurova University School of Medicine April 30th-May 4th 2003.
  • - “Training Skills Course” course manager: HASTÜRK S. Çukurova Uni. School of Medicine July 5-9, 2004.
  • - “Training Skills Course” course manager: HASTÜRK S. Çukurova Uni. School of Medicine December 20- 24, 2004.
  • -“Presentation planning and Event Managing” course trainer: HASTÜRK S. Çukurova Uni. School of Medicine April 12-13, 2007.
  • -“Presentation planning and Event Managing” course trainer: HASTÜRK S. Çukurova Uni. School of Medicine January 31st – February 1st, 2008
  • - ’12. “Training Skills Development” course trainer: HASTÜRK S. Çukurova Uni. School of Medicine March 17-21, 2008.
  • - Lecturer in Medical Education Department: HASTÜRK S. (2009 – 2010)
 
Association and Organization Memberships
  • Turkish Association of Thorax
  • - Turkish Association of Respiratory Researches (TUSAD)
  • Turkish Society of Lung Cancer (TAKD) (Founding and Full Member)
  • European Respiratory Society (ERS)
  • International Association for the Study of Lung Cancer (IASLC)
  • American Thoracic Society (ATS)
  • American College of Chest Physicians (ACCP)
  • American Association for Cancer Research (AACR)
Scientific Studies

INTERNATIONAL PUBLICATIONS:

1. HASTÜRK S, Erdoğan Y, Özyıldırım A, Çakır E, Teke Y: Combined chemotherapy and radiotherapy in advanced pulmonary blastoma. BMJ Thorax 1995; 50: 591-592.

 

2. İçli F, Karaoğuz H, HASTÜRK S, Kurt B, Akbulut H, Dinçol D, Demirkazık A, Çay F, Akyar S: Two dose levels of ifosfamide in malignant mesothelioma. Lung Cancer 1996; 15: 207:-213.

 

3. HASTÜRK S, Taştepe İ, Ünlü M, Çetin G, Barış YI: Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients. Journal of Chemotherapy 1996; 8: 159-164.

 

4. HASTÜRK S, Kurt B, Kocabaş A, Nadirler F, Örüç O: Combination of chemotherapy and recombinant interferon-alpha in advanced non-small cell lung cancer. Cancer Letters 1997; 112: 17-22.

 

5. HASTÜRK S, Kurt B, Kocabaş A, Örüç O, Burgut R: Ifosfamide, cisplatin and etoposide (ICE) combined chemotherapy with recombinant human granulocyte colony-stimulating factor support in small cell lung cancer. Journal of Chemotherapy 1997; 9: 66-71.

 

6. Paydaş S, Abaylı B, Kocabaş A, HASTÜRK S, Gönlüşen G: Membranoproliferative glomerulonephritis associated pulmonary sarcoidosis. Nephrol Dial Transplant 1998; 13: 228-229.

7. Demirkazık A, Dinçol D, HASTÜRK S, Arıcan A, Karaoğuz H, Çay F, İçli F: Diagnostic value of ferritin in the differential diagnosis of malignant effusions. Cancer Biochem Biophys 1998; 16: 243-251.

 

8. HASTÜRK S, Soylu M, Zeren EH, Hanta I: Basaloid large cell lung carcinoma presenting concurrently with metastatic uveal tumor. Lung Cancer 2001; 32: 95-101.

 

9. Turkish Thoracic Society, Lung and Pleural Malignancies Study Group: Pattern of lung cancer in Turkey. 1994-1998. Respiration 2002; 69: 207-210.

 

10. HASTÜRK S, Kemp B, Kalapurakal SK, Kurie JM, Hong WK, Lee JS: Expression of
cyclooxgenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung
cancer. Cancer 2002; 94:1023-1031.


11. Paydas S, Yavuz S, Disel U, Zeren H, HASTÜRK S, Hanta I, Ergin M, Sahin B:
Granulomatous reaction after chemotherapy for Hodgkin’s disease. Leuk Res 2002;
26(10): 967-70.


12. HASTÜRK S, Hatabay N, Ece F, Karataşlı M, Hanta I: Gemcitabine, vinorelbine and
cisplatin in the treatment of advanced nonsmall cell lung cancer. Am J Clin Oncol 2009;
32(3) : 280-5.


13. Hanta I, Soydas Y, Karatasli M, Koseoglu S, Satar S, HASTÜRK S: Plasma homocystein
levels and 677C→ T mutation on the MTHFR gene in the patients with venous
thromboembolism. Bratisl Lek Listy 2010;111(2) : 70-73.


14. Demirhan O, Taşdemir D, HASTÜRK S, Kuleci S, Hanta İ: Alterations in p16 and p53
genes and chromosomal findings in patients with lung cancer: fluorescence in situ
hybridization and cytogenetic studies. Cancer Epidemiol. 2010 ;34(4):472-7.


15. Prabowo SA, Gröschel MI, Schmidt DL, Skrahina A, Mihaescu T, HASTÜRK S,
Mitrofanov R, at al: Targeting multidrug – resistant tuberculosis (MDR-TB) by
therapeutic vaccines. Med Microbiol Immunol Publish online November 2012.


16. Taştemir-Korkmaz D, Demirhan O, Kuleci S, Hastürk S: There is no significant
association between death receptor 4 (DR4) gene polymorphisms and lung cancer in
Turkish population. Pathol Oncol Res. 2013; 19(4):779-84.

NATIONAL PUBLICATIONS

1. Türktaş H, DEMIREL S, Çetin G: Monitoring of the patients who underwent diagnostic thoracotomy due to solitary lung nodule within last two years. Journal of Tuberculosis and Thorax, 1989; 35: 283-286.


2. Örüç O, Özkara Ş, DEMİREL S, Başer Y: Hospital costs for patients with pulmonary hydatid cyst. Respiratory Diseases, 1990; 1: 23-26.


3. DEMİREL S, Kural T, Akgün G, Akalın H, Çorapçıoğlu T: Left ventricle aneurism complication with non-fatal rupture in myocardial infarction.  Ankara Medical Journal 1990; 43: 691-702.


4. DEMİREL S, Türktaş H, Uğur P, Özyıldırım A, Önde G: Chemotherapy results of a group that consists of patients with primary lung cancer. Respiratory Diseases, 1991; 2: 129-137.


5. Güler M, Arab C, Yener O, Kalaç N, DEMİREL S, Alın H: Possibility of malignancy in eosinophilic pleural effusions. Respiratory Diseases, 1992; 3: 335-340.


6. DEMİREL S; Akgün G, Gürel T: HGL levels in acute myocardial infarction. Ankara Medical Journal 1993; 46: 85-92.


7. Kaya S, HASTÜRK S, Aksu Ö, Yalçınkaya İ, Balkan E: Chest wall rhabdomyosarcoma due to a case, Türkiye Klinikleri Journal Medical Science 1993; 13: 270-273.


8. HASTÜRK S, Erdoğan Y, Çakıroğlu E, Teke Y: Pulmonary blastoma (due to one case).
Turkish Hematology & Oncology Journal 1993; 3: 116-120.


9. HASTÜRK S, Kurt B, Nadirler F, Örüç O: Comparision of ondansetron-dexamethasone with metoclopramide-dexamethasone in the control of cisplatin induced emesis. Turk J Me Res, 1993; 11: 131-135.


10. HASTÜRK S, Kurt B, Nadirler F, Özyıldırım A, Örüç O, Ünlü M: Mitomycin, ifosfamide, cisplatin combined chemotherapy in inoperable small cell and non small cell lung cancer.
Turkish Hematology & Oncology Journal 1993; 3: 183-186.


11. HASTÜRK S, Alpar S, Güllü İ, Kurt B, Özbudak Ö, Örüç O: Vena cana superior syndrome that developed in a patient with operated ovarian carcinoma (case report) Turkish Hematology & Oncology Journal 1994; 4: 45-49.


12. HASTÜRK S, Kurt B, Alpas S, Nadirler F, Örüç O: Study of cases with second primary lung cancer. ACTA Oncologica Turcica 1994; 27: 39-42.

13. HASTÜRK S, Özbudak Ö, Kurt B, Gözü A, Örüç O: A Wegener granulomatosis case that shows rapid fatal course (case report). ACTA Oncologica Turcica 1994; 27: 97-99.


14. Kurt B, Selçuk Ö, HASTÜRK S, Nadirler F, Örüç O: Empiric anti-biotic therapy for patients with malignancy. Respiratory Diseases, 1995; 6: 11-16.


15. Güler M, Kurt B, Dursun G, HASTÜRK S, Kaya S: Hodgkin’s disease with lung parenchyma involvement (due to a case). Respiratory Diseases, 1995; 6: 75-82.


16. HASTÜRK S, Kurt B; Özyıldırım A, Bilgin S, Örüç O: Chemotherapy induced nail hyperpigmentation (melanonychia). J Ankara Medical School 1995; 17: 315-319.


17. DEMİREL S, Bilgin S, Kurt B, Örüç O: A systemic lupus erythematous (SLE) case with bilateral pleural effusion as the first symptom. Journal of Tuberculosis and Thorax, 1995; 43: 224-227.


18. HASTÜRK S, Kurt B, Kocabaş A, Nadirler F, Örüç O: Combination of chemotherapy and
recombinant interferon alpha in advanced non-small cell lung cancer. Acta Oncologica
Turcica 1996; 29: 91-95.


19. HASTÜRK S, Kurt B, Kocabaş A, Örüç O, Burgut R: High dose ifosfamide, cisplatin and
etoposide (ICE) combined chemotherapy with recombinant human granulocyte colonystimulating factor support in small cell lung cancer. Acta Oncologica Turcica 1996; 29:14-18.


20. Kurt B, HASTÜRK S; Gülhan M, Alpar S, Örüç O: Carboplatin, ifosfamide and etoposide
combination in advanced non small cell lung cancer. ActaONcologica Turcica 1996; 29:
4-8.


21. HASTÜRK S, Alpas S, Özyıldırım A, Kurt B, Örüç O: The effect of
medroxyprogesterone acetate to weight gain and performance status in lung cancer.
Turkish J Medical Research 1996; 14(2): 74-77.


22. Alpar S, HASTÜRK S, Uçar N, Kurt B, Burgut R, Örüç O: Serum vitamin A and vitamin B12 levels in patients with epidermoid lung cancer. Heybeliada Med. Bulletin, 1996:2(3):
65-68.


23. HASTÜRK S, Canpınar H, Alpar S, Kürkçüoğlu C, Kocabaş A, Burgut R, Kansu E:
Prognostic significance of flow cytometry in non-small cell lung cancer. A preliminary
study. Heybeliada Med. Bulletin, 1996:2(3): 29-34.


24. HASTÜRK S, Kurt B, Çetin G, Ünlü M, Burgut R: Adjuvant chemotherapy in patients
with completely resected stage II and III non-small cell lung cancer. Respiratory Diseases, 1996; 7(3): 655-669.


25. HASTÜRK S: Flow cytometry and its prognostic importance in non small cell lung cancers. Respiratory Diseases, 1997; 8(2): 335-347.


26. HASTÜRK S, Aydilek R: Lung cancer: Actual Medicine Journal 1999; 4: 183-186.


27. HASTÜRK S: Diagnostic approach to acute pulmonary embolism clinic. Actual Medicine Journal 2002; 7: 36-44.


28. HASTÜRK S: Treatment of acute pulmonary embolism. Actual Medicine Journal 2002; 7: 45-52.


29. HASTÜRK S: Spontaneous hydropneumothorax: An unusual presentation of malign
pleural mesothelioma. Turkish Respiratory Journal 2002; 3(3) : 127-129.


30. HASTÜRK S: Molecular biology of lung cancer. Türkiye Klinikleri (Pulmonary Diseases Special Issue) 2014; 7(1): 12-19.

 

 

BOOK CHAPTERS


1. Kocabaş A, HASTÜRK S: Obstructive lung diseases (Ed: İliçin, Ünal, Berberoğlu,
Akalın, Süleymanlar: Basic internal diseases) Güven Kitabevi, Ankara, Ankara, Volume 1; 496-511, 1996.


2. HASTÜRK S: Differential diagnosis of bronchial asthma. (Ed: Aydilek R: Allergic diseases and bronchial asthma) Özlem Grafik Matbaacılık Ltd Şti, İstanbul, Volume 2; 445-462, 1998.3. HASTÜRK S: Molecular biology of lung cancer. (Ed:Hastürk S, Yüksel M:
Lung Cancer) Özlem Grafik Matbaacılık, İstanbul,1-27,2000.


4. HASTÜRK S: Adjuvant chemotherapy in early stage non small cell lung cancer (Ed: Hastürk S, Yüksel M: Lung Cancer) Özlem Grafik Matbaacılık, İstanbul,131-140, 2000.


5. HASTÜRK S: Multiple modeled therapy in regionally spread non small cell lung cancer (Ed: Hastürk S, Yüksel M: Lung Cancer) Özlem Grafik Matbaacılık, İstanbul,131-152, 2000.

6. HASTÜRK S: Chemotherapy in metastatic non-small cell lung cancer (Ed:
Hastürk S, Yüksel M: Lung Cancer) Özlem Grafik Matbaacılık, İstanbul, 245-258, 2000.


7. HASTÜRK S: Approach to geriatric patients with lung cancer. (Ed: Engin K, Özyardımcı N:
Lung Cancer in 2000s) Mart Matbaacılık Sanatları Ltd.Şti. , Bursa, 372-383,2001.


8. HASTÜRK S: Pulmonary hypertension. Translation Ed: Özcengiz D. (Schaefer OP, Rubin LJ:
Pulmoner Hypertension in Eds: Irwin RS, Rippe JM: Manual of Intensive Care Medicine, Lippincott Williams&Wilkins, 2000 ) Manual of Intensive Care Medicine; Nobel Tıp Kitapevi 298–302,2002.


9. HASTÜRK S: Chronic obstructive pulmonary disease. Translation Ed: Özcengiz D. (Schaefer OP,
Lapinsky SE, GrossmanRF: Chronic Obstructive Pulmonary Dısease; in Eds: Irwin RS, Rippe JM: Manual of Intensive Care Medicine, Lippincott Williams&Wilkins, 2000 ) Manual of Intensive Care Medicine; Nobel Tıp Kitapevi 268–272,2002.


10. HASTÜRK S: Acute infectious pneumonia. Translation Ed: Özcengiz D.(Schaefer OP, Niederman MS: Acute Infectious Pnomonia; in Eds: Irwin RS, Rippe JM: Manual of Intensive Care Medicine, Lippincott Williams&Wilkins, 2000 ) Manual of Intensive Care Medicine; Nobel Tıp Kitapevi 346–351,2002.


11. HASTÜRK S: Asthma attack. Translation Ed: Özcengiz D. (Madisonand JM, Irwin RS: Status Asthmaticus; in Eds: Irwin RS, Rippe JM: Manual of Intensive Care Medicine, Lippincott Williams&Wilkins, 2000 ) Manual of Intensive Care Medicine; Nobel Tıp Kitapevi 264-267,2002.


12. HASTÜRK S: Respiratory Therapy. Translation Ed: Özcengiz D. (French CT, Irwin RS:
Respiratory Therapy; in Eds: Irwin RS, Rippe JM: Manual of Intensive Care Medicine, Lippincott Williams&Wilkins, 2000 ) Manual of Intensive Care Medicine; Nobel Tıp Kitapevi 319–324,2002.


13. HASTÜRK S: Stable asthma therapy for adults. (Ed: Narlı N, Karataş Y: Manual for General Medicine Practitioners) Nobel Yayınevi, Adana, 119–122,2004.


14. HASTÜRK S: Approach to patients with respiratory system related diseases. Translation Ed:
Sağlıker Y (Drazen JM, Weinberger SE in Eds: Braunwald E, Fauci A, Kasper DL,
Hauser SL, Longo DL, Jameson JL. Harrison’s Principles of Internal Medicine; McGrawHill Comp. Inc) Harrison’s Principles of Internal Medicine; Cilt 2, Nobel Tıp Kitabevleri Ltd Şti,
İstanbul, 1443–1446 , 2004.

 

15. HASTÜRK S: Respiratory dysfunctions. Translation Ed: Sağlıker Y (Weinberger SE, Drazen JM in Eds: Braunwald E, Fauci A, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison’s Principles of Internal Medicine; McGrawHill Comp. Inc) Harrison’s Principles of Internal Medicine; Cilt 2, Nobel Tıp Kitabevleri Ltd Şti, İstanbul, 1446-1453 , 2004.


16. HASTÜRK S: HASTÜRK S: Sağlıker Y (McFadden ER, in Eds: Braunwald E, Fauci A, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison’s Principles of Internal Medicine; McGraw-Hill Comp. Inc) Harrison’s Principles of Internal Medicine; Cilt 2, Nobel Tıp Kitabevleri Ltd Şti, İstanbul, 1456-1463 , 2004.


17. HASTÜRK S: Pulmonary infiltrations that associate with hypersensitivity pneumonia and eosinophilia. Translation Ed: Sağlıker Y (Kline JN, Hunninghake GW in Eds: Braunwald E, Fauci A, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison’s Principles of Internal Medicine; McGraw-Hill Comp. Inc) Harrison’s Principles of Internal Medicine; Cilt 2, Nobel Tıp Kitabevleri Ltd Şti, İstanbul, 1463-1467 , 2004.


18. HASTÜRK S: Endotelial and pulmonary diseases (Ed: Şan M: The secret strength of life, Endothelium and our Systems ) Printaş Basım AŞ, İstanbul, 133-156,2005.


19. HASTÜRK S: Inhaled nitric oxide use in patients with pulmonary hypertension and acute respiratory problem (Ed: Şan M: The secret strength of life, Endothelium and our Systems ) Printaş Basım AŞ, İstanbul, 157-168.2005.

20. HASTÜRK S: Lung disease and Dyspnea. Dyspnea; Vol 2, 26-37, 2007.
 

 

BOOKS

 

1. HASTÜRK S, Yüksel M (Ed): Lung cancer Özlem Grafik Matbaacılık, İstanbul, 2000.


2. HASTÜRK S (Ed): Inhalation therapy. Özlem Grafik Matbaacılık, İstanbul, 2002.

 


INTERNATIONAL PRESENTATIONS


1. HASTÜRK S, Kurt B, Nadirler F, Özyıldırım A, Örüç O, Ünlü M: Mitomycine,
ifosfamide and cisplatin combined chemotherapy in the treatment of inoperable non-small
cell lung cancer. ESO Seminar on Lung Cancer 1993 (12th –13th November 1993, Seminar
on Lung Cancer, Vienna, Austria).

2. HASTÜRK S, Taştepe I, Ünlü M, Çetin G, Ünal A; Barış YI: Combined chemotherapy in
pleurectomized malignant pleural mesothelioma patients. The European Journal of Cancer
1994; 34s: 168 (June 16-18, 1994; EJC, ESO, Paris, France).


3. HASTÜRK S, Alpar S, Selçuk Ö, Ertuğrul N, Kurt B, Örüç O: The effect of
medroxyprogesterone acetate to weight gain and performance status in lung cancer. The
European Respiratory Journal 1994; 392s: P1772 (1st-5th October 1994, ERS Annual
Congress, Nice, France).


4. Demirkazık A, Dinçol D, HASTÜRK S, Arıcan A, Karaoğuz H, Çay F, İçli F: The value
of ferritin in the differential diagnosis of malignant effusions. The European Journal of
Cancer 1995; s264-265/1269 (29 Oct-2 Nov 1995, The European Cancer Conference
ECCO 8, Paris, France).


5. Kurt B, HASTÜRK S, Özyıldırım A, Gülhan M: Phase II study of ifosfamide, carboplatin
and etoposide combination for advanced non-small cell lung cancer. The European
Respiratory Journal 1995; 528s: P2589 (Sept 16-20, 1995; ERS Annual Congress,
Barcelona, Spain).


6. HASTÜRK S, Kurt B, Özyıldırım A, Nadirler F, Örüç O: Combination of chemotherapy
and recombinant interferon-alpha in advanced non-small cell lung cancer. The European
Respiratory Journal 1995; 528s: P2590 (Sept 16-20, 1995; ERS Annual Congress,
Barcelona, Spain).

7. HASTÜRK S, Kurt B, Özyıldırım A, Burgut R: High dose ifosfamide, cisplatin and
etoposide (ICE) combined chemotherapy with recombinant human granulocyte colonystimulating factor support in small cel lung cancer. The European Respiratory Journal
1995; 20s: O197 (Sept 16-20, 1995; ERS Annual Congress, Barcelona, Spain).
 

8. Kocabaş A, HASTÜRK S, Yaşar M, Göçmen T, Avşar M, Çetiner S, Burgut R: Markers
for lymphocyte activation in patients with stable asthma. The European Respiratory
Journal 1995; 267s: P1344 (Sept 16-20, 1995; ERS Annual Congress, Barcelona, Spain).
 

9. Alpar S, HASTÜRK S, Kurt B, Uçar N, Burgut R, Örüç O: The diagnostic value of serum
vitamin A and vitamin B12 levels in squamous cell lung cancer. The European Respiratory
Journal 1996; 95s: PO618 (Sept 7-11, 1996; ERS Annual Congress, Stockholm, Sweden).
 

10. HASTÜRK S, Canpınar H, Alpar S, Kürkçüoğlu C, Kocabaş A: Prognostic significance
of flow cytometry in non-small cell lung cancer. The European Respiratory Journal 1996;
458s: P2841 (Sept 7-11, 1996; ERS Annual Congress, Stockholm, Sweden).
 

11. Kocabaş A, Yaşar M, Güneşacak R, HASTÜRK S: Circulating levels of TNF-a, IL-1a,
IL-6 and IL-8 in patients with mild-moderate asthma. The European Respiratory Journal
1996; 409s: P1318 (Sept 7-11, 1996; ERS Annual Congress, Stockholm, Sweden).
 

12. HASTÜRK S, Canpınar H, Alpar S, Kürkçüoğlu C, Kocabaş A, Burgut B, Kansu E:
Prognostic significance of flow cytometry in non-small cell lung cancer (a pilot study).
Lung Cancer 1996; P62 (6-3 Nov, 1996, 2nd International Congress on Lung Cancer,
Crete-Greece).
 

13. HASTÜRK S, Kurt B, Kocabaş A, Nadirler F, Örüç O: Combination of chemotherapy and
recombinant interferon-alpha in advanced non-small cell lung cancer. Lung Cancer 1996;
OP101 (6-3 Nov, 1996, 2nd International Congress on Lung Cancer, Crete-Greece).

 

14. Erkişi M, HASTÜRK S, Camcı C, Burgut R: Lymphocyte subsets in circulating blood in
lung cancer. The European Respiratory Journal 1997; 114s: P0760 (Sept 20-24, 1997;
ERS Annual Congress, Berlin, Germany).

 

15. HASTÜRK S; Tap Ö, Halefoğlu YZ, Kocabaş A, Kaya M: The effect of carbosulfan
inhalation on lung structure. The European Respiratory Journal 1997; 134s: P0950 (Sept
20-24, 1997; ERS Annual Congress, Berlin, Germany).

 

16. HASTÜRK S, Kamp B, Kalapurakal SK, Kurie JM, Hong WK, Lee JS: A study of COX1
and COX2 expression in bronchial epithelium and non-small cell lung carcinoma.
Proceeding of the American Association for Cancer Research 1999; Vol: 40, 429s, #
2836 (April 10-14, 1999; 90th Annuals Congress of AACR, Philadelphia, PA, USA).

 

17. T. Lung Pleural Malignancies Study Group, Turkey: The retrospective analysis of lung
cancer patients in Turkey, a country where smoking is highly prevalent. Lung Cancer
2001; Vol: 29 (11001): 235 # 805 (Sept 2001; 9th World Conference of Lung Cancer.
Tokyo, Japan).

 

18. HASTÜRK S, Kozanoglu M, Karataş M, Sur S: Sistemic effect of inhaled
corticosteroids on bone-mineral density in patients with asthma. Astma Actma
2003; Vol 4: 90 # 35 (July 2003; XVII World Asthma Congress. St Petersburg, Russia).

 

19. HASTÜRK S, Hanta İ, Kulecı S, Duru S: No change the relationship of lung cancer
and smoking behavior for Turkey: Based on the hospital population in the south of
Turkey. Lung Cancer 2003; Vol: 41, S115 # P-97 (Aug 2003; 10th World Conference
of Lung Cancer. Vancouver, Canada).

20. HASTÜRK S, Duru S, Karataş M, Zeren H, Burgut R: Expressions of vascular cell
adhesion molecule 1 and nm23 in advanced stage of non-small cell lung carcinoma: Prognostic significance. Lung Cancer 2003; Vol: 41, S115 # P-97 (Aug
2003; 10th World Conference of Lung Cancer. Vancouver, Canada).

 

21. HASTÜRK S, Hatabay N, Ece F, Karataşlı M, Hanta İ. Gemcitabine, vinorelbine,
and cisplatin combination chemotherapy in advanced non-small cell lung cancer.
Lung Cancer 2005; Vol 49, Suppl 2, Page S247. (11th World Conference on Lung
Cancer 3-6 July 2005 Barcelona, Spain)

 

22. Uçar G, Kuleci S, Hanta İ, HASTÜRK S, Guveloğlu E, Zeren H. Prognostic significance
of COX-2 and VEGF expression in lung cancer. Journal of Thoracic Oncology 2007;
P2_075 (12th World Conference on Lung Cancer September 2-6, Seul, Korea).

 

23. Uçar G, Hanta İ, Kuleci S, HASTÜRK S, Guveloğlu E, Zeren H. The role of human
papilloma virus in the development of lung cancer. European Respiratory Journal 2007;
Vol 30, Suppl 51, E1814. (Sept 15-19, 2007; 17th ERS Annual Congress, Stockholm,
Sweden).

 

24. Güzel R, Mungan N, Seydaoğlu G, Evliyaoğlu N, Güler T, Gurler-Uysal F, Gulsen M,
HASTÜRK S, Kasap M, Ogulener N, Ozgunen FT, Saltoğlu N, Solmaz S, Doran F.
Outcomes of three different practices of physician-patient communication module.
Association for Medical Education in Europe (AMEE) 2007; Page 84, 4P/p10. (August
25-29, 2007; AMEE 2007 Trondheim, Norway).

 

25. Demirhan O, Tastemir D, HASTÜRK S, Kuleci S, Hanta I. Alterations in p16 and p53
genes and chromosomal findings in patients with lung cancer: FISH and cytogenetic
study. European Society of Human Genetics 2009; 214. European Human Genetics
Conference May 23- 26, 2009, Vienna, Austria.

 

26. HASTÜRK S, Uçar O, Kuleci S, Sökücü S N, Altın S. PET-CT be a prognostic factor in
patients with non- small cell lung cancer? . Journal of Thoracic Oncology 2011; P2_075
(14th World Conference on Lung Cancer July 3-7, Amsterdam, The Netherlands)

 

27. HASTÜRK S, Olgunus Ö, Tuli A, Dundar E, Unlu EÖ. The prognostic value of gene
expressions of ERCC1 and RRM1 in non-small cell lung cancer. J Clin Oncol 31, 2013
(Suppl; abstr e19071). ASCO Annual Meeting May 31- June 4, 2013; Chicago/IL.

 

28. Öz B, Batur Ş, Eralp Y, HASTÜRK S, Yumuk F, Yıldız Ö, Karaoglu A.
Clinicopathological Data's of Advanced NSCLC Patients with ROS1 Gene
Rearrangement and of Clinical Responses to Crizotinib in TURKEY
 . Journal of
Thoracic Oncology 2015; P3.04-013 (16th World Conference on Lung Cancer Sep 6-9,
Denver , Colorado, USA)

 


LOCAL PRESENTATIONS


1. DEMİREL S, Türktaş H, Uğur P, Özyıldırım A, Önde G: Chemotherapy results of a group that consists of patients with primary lung cancer. Respiratory Diseases, 1990; 1: 48 (October 1-5, 1990, TÜSAD XVIII. National Congresses, Ankara).

 

2. DEMİREL S, Erdoğan Y, Çakıroğlu E, Teke Y: Pulmonary Blastoma. Congress Abstract Book 1991; 50 (June 2-7, 1991, IX. National Cancer Congress and VI. Pediatric Tumors Congress, İzmir).

 

3. Dinçol D, Demirkazık A, DEMİREL S, Günel N, Arıcan A, Karaoğuz H, İçli F:
Value of ferritin levels in differential diagnosis of effusions. Congress Abstract Book 1991; 50 (June 2-7, 1991, IX. National Cancer Congress and VI. Pediatric Tumors Congress, İzmir).

 

4. DEMİREL S, Kurt B, Nadirler F, Bilgin S, Örüç O: Comparison of anti-emetic effects of metacloropromide and ondansetron in chemotherapy protocols that include cisplatin. TÜSAD XX. National Congress Abstract Book 1992; 163 (September 27-30, 1992; TÜSAD XX. National Congresses, İstanbul).

 

5. Kurt B, DEMİREL S, Nadirler F, Bilgin S, Örüç O: Serum calcium, alkaline phosphatase and glutamine trans-peptidase levels in epidermoid carcinoma. TÜSAD XX. National Congress Abstract Book 1992; 172 (September 27-30, 1992; TÜSAD XX. National Congresses, İstanbul).

 

6. DEMİREL S, Bilgin S, Kurt B, Özyıldırım A, Örüç O: Melanonychia (due to two cases) TÜSAD XX. National Congress Abstract Book 1992; 210 (September 27-30, 1992; TÜSAD XX.
National Congresses, İstanbul).

 

7. DEMİREL S, Kurt B, Nadirler F, Evci E, Örüç O: Study of cases with second primary lung cancer. TÜSAD XX. National Congress Abstract Book 1992; 168 (September 27-30, 1992; TÜSAD XX. National Congresses, İstanbul).

 

8. DEMİREL S, Kurt B, Nadirler F, Öztürk H, Örüç O: Ifosfamid therapy in pleural malign mesothelioma. TÜSAD XX. National Congress Abstract Book 1992; 165 (September 27-30, 1992; TÜSAD XX. National Congresses, İstanbul).

 

9. HASTÜRK S; Alpas S, Kurt B, Gözü A, Selçuk Ö, Özbudak Ö, Örüç O: Effect of medroxyprogesterone acetate (MPA) on general performance in patients with intra-thoracic malignancy. TÜSAD XXI. National Congress Abstract Book 1993; P129 (October 24-28, 1993; TÜSAD XXI. National Congress, Kuşadası).

 

10. HASTÜRK S, Kurt B, Örüç O, Taştepe İ, Kaya S, Ünlü M, Çetin G: Postoperative chemotherapy in patients with malign mesothelioma. TÜSAD XXI. National Congress Abstract Book 1993; P60 (October 24-28, 1993; TÜSAD XXI. National Congress, Kuşadası).

 

11. HASTÜRK S, Özbudak Ö, Kurt B, Gözü A, Örüç O: A Wegener granulomatosis case with fatal course TÜSAD XXI.  National Congress Abstract Book 1993; P4 (October 24-28, 1993; TÜSAD XXI. National Congress, Kuşadası).

 

12. HASTÜRK S, Alpar S, Güllü İ, Kurt B, Özbudak Ö, Örüç O: Vena cana superior syndrome that developed in a patient with operated ovarian carcinoma (case report) TÜSAD XXI. National Congress Abstract Book 1993; P129 (October 24-28, 1993; TÜSAD XXI. National Congress, Kuşadası).

 

13. HASTÜRK S, Kurt B, Nadirler F, Özyıldırım A, Örüç O, ÜNlü M, Güler N, Tekuzman G: Mitomycin, ifosfamide, cisplatin combined chemotherapy in inoperable non small cell lung cancer.  X. National Cancer Congress Abstract Book 1993 (May 3-7, 1993, X. National Cancer Congress, İstanbul).

 

14. Karaoğuz H, İçli F, HASTÜRK S, Dinçol D, Günel N, Demirkazık A, Üner A, Çay F:
Ifosfamide therapy in irresectible diffuse malign mesothelioma. X. National Cancer Congress Abstract Book 1993 (May 3-7, 1993, X. National Cancer Congress, İstanbul).

 

15. Dinçol D, Demirkazık A, DEMİREL S, Arıcan A, Karaoğuz H, Günel N, Üner A, Çay F,
İçli F: Ferritin level in differential diagnosis of malign pleural effusion and ascites. X. National Cancer Congress Abstract Book 1993 (May 3-7, 1993, X. National Cancer Congress, İstanbul).

16. HASTÜRK S, Kurt B, Özyıldırım A, Örüç O: High dose ifosfamide, cisplatin, etoposide (ICE) therapy in patients with small cell lung cancer. TÜSAD XXII. National Congress Abstract Book 1994; P83 (September 18-21 1994, TÜSAD XXII. National Congress, Nevşehir).

 

17. Kurt B, HASTÜRK S, Nadirler F: Cisplatin, vepesid, alpha interferon therapy in inoperable non-small cell lung cancer. TÜSAD XXII. National Congress Abstract Book 1994; TP30 (September 18-21 1994, TÜSAD XXII. National Congress, Nevşehir).

 

18. Üner A, İçli F, HASTÜRK S, Günel N: Tissue polypeptide specific antigen and neuron specific enolase in non-small cell lung cancers. Turkish Oncology Journal 1995; 10: 75C-196 (XI. National Cancer Congress, Antalya).

 

19. Üner A, İçli F, HASTÜRK S, Günel N: A new contribution to neuron specific enolase in small cell lung cancer: Prognostic importance of tissue polypeptide specific antigen. Turkish Oncology Journal 1995; 10: 75C-197 (XI. National Cancer Congress, Antalya).

 

20. HASTÜRK S, Kurt B, Özyıldırım A, Çetin G, Ünlü M, Burgut R: Adjuvant chemotherapy in patients with operated non-small cell lung cancer. Turkish Oncology Journal 1995; 10: 79/C-214 (XI. National Cancer Congress, Antalya).

 

21. Alpar S, HASTÜRK S, Selçuk Ö, Kurt B, Burgut R, Örüç O: Serum retinol and vitamin B12 levels in patients with epidermoid lung cancer. TUSAD XXIII. National Congress Abstract Book 1995; TP95 (June 11-14, 1995; TÜSAD XXIII. National Congresses, İstanbul).

 

22. Kurt B, HASTÜRK S, Özyıldırım A, Gülhan M: Combined chemotherapy consisting of Cyclophosphamide, Etoposide and Cisplatin in advanced stage non-small cell lung cancer, phase II study.
TUSAD XXIII. National Congress Abstract Book 1995; TP46 (June 11-14, 1995; TÜSAD XXIII. National Congresses, İstanbul).

 

23. Kocabaş A, HASTÜRK S, Yaşar M, Göçmen T, Avşar M, Çetiner S, Burgut R: Serum lymphocyte activation markers in patients with mild-moderate asthma. Thoracic Society I. Annual Congress Abstract Book 1996, 77: 293 (May 6-10, 1996, Thoracic Society I. Annual Congress, Nevşehir).

 

24. Kocabaş A, Yaşar M, İdrisoğlu Ş, Erken E, HASTÜRK S, Burgut R: Value of phadiatop and total serum IgE levels on identification of respiratory system allergy. Thoracic Society I. Annual Congress Abstract Book 1996, 42: 150 (May 6-10, 1996, Thoracic Society I. Annual Congress, Nevşehir).


25. HASTÜRK S; Canpınar H, Alpar S, Kürkçüoğlu C, Demircan S, kocabaş A, Burgut R,
Kansu E: Prognostic importance of DNA ploidy of patients with non-small cell lung cancer. Thoracic Society I. Annual Congress Abstract Book 1996, 57: 213 (May 6-10, 1996, Thoracic Society I. Annual Congress, Nevşehir).


26. HASTÜRK S, Kurt B, Çetin G, Ünlü M, Burgut R: Adjuvant chemotherapy in patients
with completely resected stage II and III non-small cell lung cancer. Marmara Medical
Journal 1996; 9: S46 (5th Marmara Medical Days Sept 16-19, 1996, İstanbul).


27. HASTÜRK S, Alpar S, Özyıldırım A, Kurt B, Örüç O: The effect of
medroxyprogesterone acetate on weight-gain and performance status in lung cancer.
Marmara Medical Journal 1996; 9: S47 (5th Marmara Medical Days Sept 16-19, 1996,
İstanbul).


28. HASTÜRK S, Tap Ö; Halefoğlu YZ, Kocabaş A, Kaya M: Effect of acute carbosulfan inhalation on thin structure of lungs. TÜSAD XXIV. National Congress Abstract Book 1997; P17 (June 8-11, 1997; TÜSAD XXIV. National Congresses, İstanbul).


29. Onur H, İçli F, Akbulut H, HASTÜRK S, Kurt B, Büyükçelik A: Contribution of adding interferon-alpha 2A into high dose ifosfamid therapy to prognosis in irresectible malign pleural mesothelioma (MPM). XIII. National Cancer Congress, 1999; 19: S75 (XIII: National Cancer Congress, 27th April-1st May 1999, Belek-Antalya).


30. HASTÜRK S, Attila GE, Canacankatan N, Aydın Ö, Karataşlı M: Effects of carbosulfan
on antioxidants. 2nd International Meeting on Free Radicals in Health and Disease 2000;
O-20 (2nd International Meeting on Free Radicals in Health and Disease May 8-12, 2002,
İstanbul-Turkey).


31. HASTÜRK S: Treatment and prognosis in hypersensitivity pneumonia. Allergy and Immunology Journal 2002; 157. (X. National Allergy and Clinical Immunology Congress September 24-27, 2002, Adana).


32. Uçar G, Hanta İ, Kuleci S, HASTÜRK S, Güveloğlu E, Zeren H: Role of human papilloma virus in development of lung cancer. Turkish Thoracic Society 10th Annual Congress Abstract Book 2007; 8:  165 (April 25-29, 2007, Kemer, Antalya)


33. Uzel FI, HASTÜRK S, Bozkurt M, Öz B, Külahçı Ç: Metastasis of lung Adenocarcinoma to peritoneum. National Lung Cancers Congress Abstract Book 2015; 179: P32

 

 



Up